Clinical Trials in Maryland

Showing 7261-7280 of 17,687 trials

Evaluating Behavioral Activation Efficacy in Depressed Spanish-Speaking Latinos

NCT01958840

Following a small, open-label pilot study that yielded very promising results of BATD, the current study will consist of a larger, randomized control trial (n=60) that will compare BATD to Supportive Counseling in outcomes of depression, contact with positive reinforcement in the environment, treatment satisfaction, therapeutic alliance, and perceived stigma. In addition, participants' adherence rates to each of the therapies and their maintenance of clinical gains at a 1-month follow-up, will be examined.

Depression

University of Maryland, College Park46 participantsStarted Aug 2013

College Park, Maryland, United States

COMPLETEDPhase 211 miles

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications

NCT04373460

To assess the efficacy and safety of Human coronavirus immune plasma (HCIP) to reduce the risk of hospitalization or death, the duration of symptoms and duration of nasopharyngeal or oropharyngeal viral shedding.

SARS-CoV 2

Johns Hopkins University1,225 participantsStarted Jun 2020

Birmingham, Alabama, United States • Chinle, Arizona, United States • Phoenix, Arizona, United States +26 more locations

Evaluating Behavioral Activation Efficacy in Depressed Spanish-Speaking Latinos

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications

Find Trials by Condition in Maryland

Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults

The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel Disease

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

Study of Diroximel Fumarate in the Real-World Setting

CoreValve Evolut Pro Prospective Registry

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

Aligning Medications With What Matters Most

Retrospective Review of Xen Gel Stent Implantation With Open vs. Closed Conjunctiva Approach

Oral AMXT 1501 Dicaprate in Combination With DFMO

Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30 Patients With Breast Cancer-Related Lymphedema.

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

A Clinical Study of Efficacy, Safety, Tolerability and PK of ND0612H in Subjects With Advanced Parkinson's Disease